Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $74.7350 (-11.61%) ($74.7350 - $74.7350) on Tue. Dec. 29, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.32% (three month average) | RSI | 80 | Latest Price | $74.7350(-11.61%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -2.2% a day on average for past five trading days. | Weekly Trend | EDIT advances 19.2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(64%) IWO(60%) IWC(57%) IBUY(56%) ARKG(55%) | Factors Impacting EDIT price | EDIT will decline at least -3.66% in a week (0% probabilities). VIXM(-30%) UUP(-15%) VXX(-12%) TBT(-7%) UNG(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.66% (StdDev 7.32%) | Hourly BBV | 0.2 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $81.18(-7.94%) | 10 Day Moving Average | $75.01(-0.37%) | 20 Day Moving Average | $61.15(22.22%) | To recent high | -11.6% | To recent low | 175.9% | Market Cap | $4.641b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |